Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Biomaterials. 2012 Oct 24;34(3):685–695. doi: 10.1016/j.biomaterials.2012.09.081

Figure 3.

Figure 3

Advanced glycation end products and lipid peroxidation products in explanted scaffolds. (top panel) Immunohistochemical detection of carboxymethyl lysine (CML) in non-treated and PGG-treated collagen and elastin scaffolds implanted in control and diabetic rats (positive=brown). (bottom panel) Pentosidine (left) and malondialdehyde (MDA, right) content in non-treated and PGG-treated collagen and elastin scaffolds after implantation in diabetic rats. *indicates statistical significance.